A tiny spoonful of caviar, just one scoop of ice-cream: operators are creating smaller, more luxurious menus, fighting to ...

Costs to Delaware patients and health insurers for GLP-1 drugs have remained flat while utilization has more than doubled in recent years.

Key Takeaways Half of people taking semaglutide for weight loss drop it within a yearThe cost of the medication appears to be ...

Hi, this is Naomi. I’m off to Vienna for a diabetes conference, and I’ve come across a lesser-known GLP-1 side effect. More ...

Powered Eye Scan Predicts Dementia Risk Years Before Symptoms: Study FindsA recent study led by researchers from the Yong Loo ...

Singer-songwriter Lizzo is burning extra pounds and turning heads. The singer donned a chic sheer ensemble as she sat front ...

VANCOUVER, BC / ACCESS Newswire / September 15, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT) is pleased to announce the successful completion of ...

Microdosing weight loss drugs, a growing global trend, could offer a new gateway solution for obesity for those priced out of ...

Biocon CEO Siddharth Mittal reveals plans to launch generic versions of diabetes drug Ozempic in key markets by the end of ...

Nearly 1 in 8 Americans have tried Ozempic or similar GLP-1 weight-loss drugs, RAND reports. Usage is highest among women ...

The $5.7 billion Indian drug maker is building capacity to tap into the massive opportunity from GLP-1 drugs to open up in ...

UK health authorities are raising concerns about the illegal sale of unapproved weight-loss injections, like Retatrutide, on ...